↓ Skip to main content

The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy

Overview of attention for article published in Frontiers in oncology, November 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
7 Mendeley